Guiding the use of physical restraints in ICU patients
Impact of a Decision-making Tool to Guide the Use of Physical Restraints in Intensive Care Unit Patients. A Multicentre Randomized Stepped-wedge Trial.
This study is testing a new tool to help doctors decide when to use physical restraints on ICU patients to improve their safety and care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 4000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 20 sites (Aurillac and 19 other locations) |
| Trial ID | NCT04957238 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a decision-making tool designed to guide the use of physical restraints in Intensive Care Unit (ICU) patients. The tool incorporates objective criteria, including the Richmond Agitation-Sedation Scale (RASS) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU), to reduce the subjectivity in the decision-making process. By assessing patients' neurological status and other factors, the study seeks to improve patient safety and care in the ICU setting. The intervention will be implemented in multiple hospitals to gather diverse data on its impact.
Who should consider this trial
Good fit: Ideal candidates include adult patients over 18 years old who have been hospitalized in the ICU for at least 48 hours.
Not a fit: Patients who are expected to remain under deep sedation throughout their ICU stay may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance patient safety and reduce unnecessary physical restraint use in critically ill patients.
How similar studies have performed: While the use of decision-making tools in clinical settings is common, this specific approach to guiding physical restraint use in ICU patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient, male or female, over 18 years of age, hospitalized in ICU for at least 48 hours. * Consent to participate in the patient's study or authorization to carry out the research collected from the designated trustworthy person (failing this, a family member, or failing this, a close and stable relation with the person concerned) according to the modalities described in Title II of the book of the First Public Health Code. If no relative is present, the patient may be included on the advice of the investigator (article L. 1111-6). A consent form for continuation of the study and use of the data will then be signed by the patient if and when the patient is again conscious and lucid, or if the patient is unable to express consent, authorization to continue the research will be obtained from the designated trusted person. * Patient covered by a social security system. Exclusion Criteria: * Predictable and uninterrupted maintenance of deep sedation throughout the duration of the stay, due to the seriousness of the lesions, from the moment the patient is admitted to the intensive care unit. * Lack of predictable remission of a severe coma present on admission to intensive care. * Refusal to participate by the patient, or by the trusted person contacted by default. * Patient with DNR (do not resuscitate) orders. * Patient under legal protection. * Patient already included in the protocol during another stay in resuscitation
Where this trial is running
Aurillac and 19 other locations
- CH Henri Mondor — Aurillac, France (Recruiting)
- Centre Hospitalier d'Avignon — Avignon, France (Recruiting)
- Hôpital Nord Franche-Comté — Belfort, France (Recruiting)
- Centre de Lutte Contre le Cancer Jean-Perrin — Clermont-Ferrand, France (Recruiting)
- Centre Hospitalier Universitaire de Clermont-Ferrand — Clermont-Ferrand, France (Recruiting)
- Centre Hospitalier Universitaire de Dijon — Dijon, France (Recruiting)
- Centre Hospitalier du Puy en Velay — Le Puy-en-Velay, France (Recruiting)
- Centre Hospitalier Universitaire - Hospices Civils de Lyon - Hôpital Edouard Herriot — Lyon, France (Recruiting)
- Assistance Publique-Hôpitaux de Marseille - La Timone — Marseille, France (Recruiting)
- Centre Hospitalier de Montluçon — Montluçon, France (Withdrawn)
- Centre Hospitalier Universitaire de Montpellier — Montpellier, France (Recruiting)
- Centre Hospitalier Moulins-Yzeure — Moulins, France (Recruiting)
- Centre Hospitalier Universitaire de Nice — Nice, France (Recruiting)
- Hôpital de la Pitié Salpétrière — Paris, France (Recruiting)
- CH de Saint Malo — Saint-Malo, France (Recruiting)
- Centre Hospitalier Universitaire de Saint-Etienne — Saint-Étienne, France (Recruiting)
- Centre Hospitalier de Salon-de-Provence — Salon-de-Provence, France (Recruiting)
- Centre Hospitalier Universitaire de Strasbourg - Réa Chirurgicale — Strasbourg, France (Recruiting)
- Centre Hospitalier Universitaire de Strasbourg -MIR — Strasbourg, France (Recruiting)
- Centre Hospitalier de Vichy — Vichy, France (Recruiting)
Study contacts
- Principal investigator: Périne Vidal — CHU de Clermont-Ferrand
- Study coordinator: Lise Laclautre
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: +33 4 73 754963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.